QA: Aprea Therapeutics Inc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001781983_2024_Aprea_Therapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001781983, Aprea Therapeutics Inc

  xvar xval
0 AssetsCurrent 22,521,095
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 88,362
3 remainder_Assets 40,717
4 LiabilitiesCurrent 4,385,605
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 11,601,452
9 ResearchAndDevelopmentExpense 3,960,096
10 remainder_Expenses 74,206,518
11 remainder_Revenues 0
12 remainder_NetIncome 1,373,778
13 remainder_ComprehensiveNetIncome -114,650
  yvar yval
0 Assets 22,650,174
1 Liabilities 4,385,605
2 Expenses 89,768,066
3 Revenues 0
4 StockholdersEquity 18,264,569
5 NetIncome -88,394,288
6 ComprehensiveNetIncome -88,451,613
7 BaseVar 59,146,136
8 EconomicCapitalRatiobeforeLimitedLiability -3.60
9 EconomicCapitalRatio 0.501

Edgar->Model Mapping

Feature Distribution

Change over Time